Preview

User

Not a user? Register with this site Forgot your password?

Current Pediatrics

Advanced search

ROLE OF METABOLIC THERAPY IN TREATMENT OF MYOCARDIUM DYSTROPHY IN CHILDREN

Abstract

The objective of present research was studying of influence of co-enzyme Q10 (Kudesan) on cardiovascular system in children with myocardial dystrophy (MCD). Patients were divided on two comparable groups (n = 20 and n = 28) according to clinical symptoms of MCD, changes on electrocardiogram (ECG) and results of echocardiography. Patients received non-drug means (massage, physical training in treatment regimen, psycho- and reflexotherapy) and vasoactive, nootropic and sedative medications; patients from 2nd group were additionally treated with co-enzyme Q10 during 4 weeks. It was shown that inclusion of co-enzyme Q10 in complex treatment of MCD resulted in beneficial effect on self-feeling of child, favored to disappearance of repolarization disorders on ECG and increase of ejectional fraction. Thus, using of co-enzyme Q10 in complex treatment of children with MCD is reasonable.
Key words: children, myocardial dystrophy, co-enzyme Q10, treatment.
(Voprosy sovremennoi pediatrii — Current Pediatrics. 2010;9(5):18-23)

About the Authors

A.L. Frolenko
Regional Children’s Clinical Hospital, Orenburg
Russian Federation



M.V. Spaskova
Regional Children’s Clinical Hospital, Orenburg
Russian Federation


N.N. Kagan
Regional Children’s Clinical Hospital, Orenburg
Russian Federation


I.Yu. Skachkova
Regional Children’s Clinical Hospital, Orenburg
Russian Federation


References

1. Леонтьева И.В., Лебедькова С.Е. Миокардиодистрофия у детей и подростков. М.: Медицина. 2005. 114 с.

2. Палеев Н.Р., Нейштут Г.М., Одинокова В.А. и др. Классификация некоронарных повреждений миокарда. Кардиология. 1978; 5: 14–20.

3. Libby P. Braunwald’s Heart Disease. A textbook of Cardiovascular Medicine, 6th ed. NY: Elsevier Science. 2001. P. 1751–1792.

4. Marin G., Goldenth J.M. Cardiomyopathies and abnormal mithochondrial function. Cardiovascular Res. 1994; 28(4): 456–463.

5. Сухоруков В.С. Врожденные дисфункции митохондриальных ферментов и их роль в формировании тканевой гипоксии и связанных с ней патологических состояний. В кн.: Проблемы гипоксии: молекулярные, физиологические и медицинские аспекты. Под ред. Л.Д. Лукьяновой, И.Б. Ушакова. М.: Истоки. 2004. С. 439–455.

6. King TE. Ubiquinone proteins and cardiac mitochondria. Trumpower B.L. Function of quinones in energy conserving systems. New York: Academic Press. 1982. P. 3–25.

7. Singh R.B., Niaz M.A., Rastogi S.S. Coenzyme Q in cardiovascular. J. Assos. Physicians India. 1998; 46 (3): 299–306.

8. Школьникова М.А., Березницкая В.В. Отчет о научно-исследовательской работе по теме «Исследование действия «Кудесана» при тахиаритмиях, синдроме удлиненного интервала QT, кардиомиопатиях, экстрасистолиях, синдроме слабости синусового узла». Антиоксидантный препарат КУДЕСАН (коэнзим Q10 с витамином Е). Применение в кардиологии. М.: Медпрактика–М. 2006. Ч. I. С. 83–89.

9. Langsjoen P.H., Langsjoen A.M. Overview of the CoQ10 in cardiovascular disease. BioFactors. 1999; 9: 273–284.

10. Леонтьева И.В. Лекции по кардиологии детского возраста. М: Медпрактика–М. 2005. 536 с.

11. Пыков М.М., Ватолин К.В. Детская ультразвуковая диагностика. М.: Видар. 2001. 668 с.

12. Белозеров Ю.М., Попылико Г.Н., Болбиков В.В., Гнусаев С.Ф. Ультразвуковая семиотика и диагностика детского возраста. М: Медицинские компьютерные системы. 1995. 171 с.


Review

For citations:

Frolenko A., Spaskova M., Kagan N., Skachkova I. ROLE OF METABOLIC THERAPY IN TREATMENT OF MYOCARDIUM DYSTROPHY IN CHILDREN. Current Pediatrics. 2010;9(5):18-23.

Views: 559


ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)

"Paediatrician" Publishers LLC
Unit 4/1, 54–4 Vavilova Street, 119296, Moscow, Russian Federation
Web-site: http://www.spr-journal.ru/
E-mail: vsp@spr-journal.ru
Tel.: +7 (499) 132-02-17
Мob.: +7 (916) 650-07-42

Яндекс.Метрика

Processing of personal data
supported by NEICON (Elpub lab)